— Know what they know.
Not Investment Advice

VERV NASDAQ

Verve Therapeutics, Inc.
1W: +1.6% 1M: -0.4% 3M: +103.5% 1Y: +55.0% 3Y: -65.5%
$11.13
Last traded 2025-07-24 — delisted
NASDAQ · Healthcare · Biotechnology · $994.0M mcap · 65M float · 8.75% daily turnover · Short 48% of daily vol

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2023-10-31
Earliest Filing
2023-10-31
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named VERV in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
BEAM Beam Therapeutics Inc. partner Beam's original collaborator whose base editing programs for cardiovascular disease were the subject of the asset transf 2023-10-31 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms